MedTrace Logo

FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study

NCT00465387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2007-04-25

No results posted yet for this study

Summary

Falls and osteoporosis-related fractures cause substantial morbidity and mortality in the elderly, and are an increasingly important public health concern. A comprehensive multidisciplinary and integrated community-based approach is needed to identify and manage the population at highest risk of these complications. Unfortunately, current gaps in continuity of care and health intervention result in a sub-optimal state of health service for these individuals. The Falls, Fracture and Osteoporosis Risk Control and Evaluation (FORCE) Study is a two-year randomized controlled trial evaluated on the effect of coordinated community-based, multidisciplinary approach for fall and fracture prevention in Sault Ste. Marie.

Conditions

Interventions

BEHAVIORAL

Falls, Fractures & Osteoporosis Risk Assessment & Management

Sponsors & Collaborators

  • Sault Area Hospital

    collaborator OTHER

  • Algoma Community Care Access Centre

    collaborator OTHER

  • Pharma Companies Alliance (Aventis and Proctor & Gamble)

    collaborator UNKNOWN

  • Merck Frosst Canada Ltd.

    collaborator INDUSTRY

  • Eli Lilly and Company

    collaborator INDUSTRY

  • The Green Shield Foundation

    collaborator UNKNOWN

  • Group Health Centre

    lead OTHER

Principal Investigators

  • Patricia M. Ciaschini, MD, FRCPC · Group Health Centre, Sault Ste. Marie, ON, Canada

  • Sharon E. Straus, MD MSc FRCPC · University of Toronto, ON, Canada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Completion
2006-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00465387 on ClinicalTrials.gov